Daniel Keszthelyi
Daniel Keszthelyi
Maastricht University Medical Center
Verified email at
Cited by
Cited by
Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function
D Keszthelyi, FJ Troost, AAM Masclee
Neurogastroenterology & Motility 21 (12), 1239-1249, 2009
Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome
A Vich Vila, F Imhann, V Collij, SA Jankipersadsing, T Gurry, Z Mujagic, ...
Science translational medicine 10 (472), eaap8914, 2018
Leaky gut and diabetes mellitus: what is the link?
S De Kort, D Keszthelyi, AAM Masclee
Obesity Reviews 12 (6), 449-458, 2011
Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome
D Keszthelyi, FJ Troost, AA Masclee
American Journal of Physiology-Gastrointestinal and Liver Physiology 303 (2 …, 2012
Large-scale association analyses identify host factors influencing human gut microbiome composition
A Kurilshikov, C Medina-Gomez, R Bacigalupe, D Radjabzadeh, J Wang, ...
Nature genetics 53 (2), 156-165, 2021
Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case–control study
D Keszthelyi, SV Jansen, GA Schouten, S De Kort, B Scholtes, L Engels, ...
Alimentary pharmacology & therapeutics 32 (9), 1124-1128, 2010
Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to …
Z Mujagic, S Ludidi, D Keszthelyi, MAM Hesselink, JW Kruimel, ...
Alimentary pharmacology & therapeutics 40 (3), 288-297, 2014
Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice
Z Helyes, E Pintér, K Sándor, K Elekes, Á Bánvölgyi, D Keszthelyi, ...
Proceedings of the National Academy of Sciences 106 (31), 13088-13093, 2009
Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff
S Ludidi, JM Conchillo, D Keszthelyi, M Van Avesaat, JW Kruimel, ...
Neurogastroenterology & Motility 24 (8), 729-e346, 2012
Rome III vs Rome IV criteria for irritable bowel syndrome: a comparison of clinical characteristics in a large cohort study
L Vork, ZZRM Weerts, Z Mujagic, JW Kruimel, MAM Hesselink, JWM Muris, ...
Neurogastroenterology & Motility 30 (2), e13189, 2018
Ethanol impairs intestinal barrier function in humans through mitogen activated protein kinase signaling: a combined in vivo and in vitro approach
E Elamin, A Masclee, F Troost, HJ Pieters, D Keszthelyi, K Aleksa, ...
PloS one 9 (9), e107421, 2014
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
C Stillhart, K Vučićević, P Augustijns, AW Basit, H Batchelor, TR Flanagan, ...
European Journal of Pharmaceutical Sciences 147, 105280, 2020
Effects of the somatostatin receptor subtype 4 selective agonist J‐2156 on sensory neuropeptide release and inflammatory reactions in rodents
Z Helyes, E Pintér, J Németh, K Sándor, K Elekes, A Szabo, G Pozsgai, ...
British journal of pharmacology 149 (4), 405-415, 2006
Efficacy and safety of peppermint oil in a randomized, double-blind trial of patients with irritable bowel syndrome
ZZRM Weerts, AAM Masclee, BJM Witteman, CHM Clemens, B Winkens, ...
Gastroenterology 158 (1), 123-136, 2020
Markers for visceral hypersensitivity in patients with irritable bowel syndrome
S Ludidi, Z Mujagic, D Jonkers, D Keszthelyi, M Hesselink, J Kruimel, ...
Neurogastroenterology & Motility 26 (8), 1104-1111, 2014
Gastrointestinal disorders in joint hypermobility syndrome/Ehlers‐Danlos syndrome hypermobility type: A review for the gastroenterologist
AB Beckers, D Keszthelyi, A Fikree, L Vork, A Masclee, AD Farmer, Q Aziz
Neurogastroenterology & Motility 29 (8), e13013, 2017
Incidence of microscopic colitis in the Netherlands. A nationwide population-based study from 2000 to 2012
BPM Verhaegh, DMAE Jonkers, A Driessen, MP Zeegers, D Keszthelyi, ...
Digestive and liver disease 47 (1), 30-36, 2015
Alterations in serotonin metabolism in the irritable bowel syndrome
AY Thijssen, Z Mujagic, D Jonkers, S Ludidi, D Keszthelyi, MA Hesselink, ...
Alimentary Pharmacology & Therapeutics 43 (2), 272-282, 2016
Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review
Z Vinarov, M Abdallah, JAG Agundez, K Allegaert, AW Basit, ...
European Journal of Pharmaceutical Sciences 162, 105812, 2021
Revisiting concepts of visceral nociception in irritable bowel syndrome
D Keszthelyi, FJ Troost, M Simrén, S Ludidi, JW Kruimel, JM Conchillo, ...
European journal of pain 16 (10), 1444-1454, 2012
The system can't perform the operation now. Try again later.
Articles 1–20